SCHEDULE OF WARRANTS (Details) - Warrant [Member] - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Number of Warrants, Outstanding, Beginning | 110,756 | |
| Weighted Average Exercise Price, Outstanding, Beginning | $ 158.35 | |
| Weighted Average Remaining Contractual Term, Outstanding | 3 years 5 months 4 days | 3 years 11 months 4 days |
| Number of Warrants, Granted | ||
| Weighted Average Exercise Price Granted | ||
| Number of Warrants, Vested or released | ||
| Weighted Average Exercise Price, Vested or released | ||
| Number of Warrants, Forfeitured | ||
| Weighted Average Exercise Price, Forfeited | ||
| Number of Warrants, Outstanding, Ending | 110,756 | 110,756 |
| Weighted Average Exercise Price, Outstanding, Ending | $ 158.35 | $ 158.35 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments granted weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options forfeited weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|